Gilead Sciences Inc. (GILD)

Index:

Nasdaq 100

$ 116.78
   
  • Change Today:
    $3.20
  • 52 Week High: $121.40
  • 52 Week Low: $84.43
  • Currency: US Dollars
  • Shares Issued: 1,246.00m
  • Volume: 8,712,575
  • Market Cap: $145,508m
  • RiskGrade: 120

Latest ShareCast News

GSK's ViiV says trial indicates HIV shot as effective as rival Gilead pill

By Frank Prenesti

Date: Thursday 23 Feb 2023

(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GILD Market Data

Currency US Dollars
Share Price $ 116.78
Change Today $ 3.20
% Change 2.82 %
52 Week High $121.40
52 Week Low $84.43
Volume 8,712,575
Shares Issued 1,246.00m
Market Cap $145,508m
RiskGrade 120

Trades for 07-Oct-2025

Time Volume / Share Price
15:59 100 @ $116.79
15:59 108 @ $116.80
15:59 100 @ $116.80
15:59 100 @ $116.80
15:59 100 @ $116.80

Top of Page